All data are based on the daily closing price as of October 8, 2025
c

Caregen

214370.KQ
45.10 USD
0.47
+1.05%

Overview

Last close
45.10 usd
Market cap
484.54M usd
52 week high
50.38 usd
52 week low
11.20 usd
Target price
26.65 usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
38.4664
Price/Book Value
14.3766
Enterprise Value
2.16B usd
EV/Revenue
38.0573
EV/EBITDA
74.6614

Key financials

Revenue TTM
45.58M usd
Gross Profit TTM
31.88M usd
EBITDA TTM
23.06M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
172.89M usd
Net debt
N/A usd

About

Caregen Co., Ltd. engages in the research, development, and commercialization of biomimetic peptides and growth factors worldwide. The company offers cosmeceutical products and food supplements under the Dermaheal, Renokin, Deglusterol, PURILUX, Pelo Baum, Pim-Pim-Paul, Neovert, and PTx brands. It also provides medical devices under the REVOFIL, DR.CYJ, PROSTROLANE, PROSTROLANE B-Series, and CG Styler 600 names. The company's products are used in anti-aging, anti-pigmentation, anti-hair loss, anti-inflammation, and other skin troubles, as well as blood sugar control, baby skin care, and acute muscle pain applications. In addition, its products in pipeline include pharmaceuticals in the areas of wet and dry macular degeneration, diabetic retinopathy, cataract, hyperhidrosis, pain relief, obesity, psoriasis, scar, arthritis, rhinitis, anti-virus, and Covid-19 treatment; and medical devices for face beauty treatment, scalp and hair improvement, body care, arthritis, and new face beauty treatment. Further, the company is developing cosmeceutical produts for anti-wrinkle, whitening, sun block, atopic dermatitis care, particulate matter inhibition, double chin removal, dark circle care, reduction of cellulite, sebum secretion control, and pore tightening applications; and food supplements in the areas of hangover cure, cholesterol control, and body fat lipolysis. Caregen Co., Ltd. was founded in 2001 and is based in Anyang-si, South Korea.
  • Symbol
    214370.KQ
  • Exchange
    KQ
  • Isin
    KR7214370009
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Pharmaceuticals
  • CEO
    Mr. Yongji Chung Ph.D.
  • Headquarter
    Anyang-Si
  • Web site
    http://caregen.co.kr
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top